1 Treating COVID

844 bookmarks
Newest
Inadvertant intravenous injections - YouTube
Inadvertant intravenous injections - YouTube
Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab707/6353927 Background Post-vaccination myocarditis and pericarditis reported after coronavirus mRNA vaccines. The effect of accidental intravenous injection of this vaccine on the heart is unknown Methods in mice Compared difference between i.m. and i.v. injection of vaccine Clinical manifestations Histopathological changes Tissue mRNA expression Serum levels of cytokines and troponins With normal saline (NS) control Results Intravenous SARS-CoV-2 mRNA Vaccine Administration Induced Grossly Visible Pathology in Heart Only IV group developed histopathological changes of myopericarditis Evidenced by cardiomyocyte degeneration Apoptosis Necrosis with adjacent inflammatory cell infiltration Calcific deposits on visceral pericardium But Evidence of coronary artery or other cardiac pathologies was absent Spike antigen (immunostaining) occasionally found in infiltrating immune cells of the heart And in cardiomyocytes and intracardiac vascular endothelial cells The histological changes of myopericarditis after the first IV-priming dose persisted for 2 weeks and were markedly aggravated by a second IM- or IV-booster dose Numerous inflammatory cytokines found in cardiac tissue (interleukin (IL)-1β, interferon (IFN)-β, IL-6, and tumor necrosis factor (TNF)-α) in the IV group but not the IM group compatible with presence of myopericarditis in the IV group Ballooning degeneration of hepatocytes was consistently found in the IV group. All other organs appeared normal. Conclusions In vivo evidence that inadvertent intravenous injection of COVID-19 mRNA vaccines may induce myopericarditis. Brief withdrawal of syringe plunger to exclude blood aspiration may be one possible way to reduce such risk. Both Pfizer/BioNTech and Moderna have clearly stated that their vaccines should only be given via IM route Current CDC and WHO guidelines no longer recommend precautionary measures during IM vaccine administration The CDC Pink Book 2020 and WHO 2015 position paper have recommended against aspiration prior to vaccine injection so as to minimize pain Deltoid to the vastus lateralis? Our study indicates that IV injection of vaccines might partially contribute to this clinical phenotype, thus warranting a reconsideration of the practice of IM injection without aspiration, which carries the risk of inadvertent IV injection. Thrombocytopenia in mice reported in 2006 Blood, (2006) https://ashpublications.org/blood/article/109/7/2832/125650/Adenovirus-induced-thrombocytopenia-the-role-of All mice received virus through a single tail vein injection Thrombocytopenia has been consistently reported following the administration of adenoviral gene transfer vectors.
·youtube.com·
Inadvertant intravenous injections - YouTube
Ivermectin or Molnupiravir - YouTube
Ivermectin or Molnupiravir - YouTube
Link to featured video https://www.youtube.com/watch?v=ctwX1cz_-dw&t=323s Link to Wefwafwa’s channel https://www.youtube.com/channel/UCzsLklGgOttU3Se-WGLp7ow (he needs more subscribers) Link to support Wefwafwa’s work in Africa patreon:https://www.patreon.com/awmedicalvideos Drugs Shown to Inhibit SARS-CoV-2 in COVID-19 Disease: Comparative Basic and Clinical Pharmacology of Molnupiravir and Ivermectin https://austinpublishinggroup.com/pharmacology-therapeutics/fulltext/ajpt-v9-id1149.pdf https://www.linkedin.com/in/leslie-adesuyi-ajayi-md-phd-fbpharmacols-fwacp-69154a38/ There are still many nations where vaccines are not yet widely available, There is a gradual shift in focus, to antiviral drugs, Adjunctive chemoprophylaxis Active treatment of new SARS-CoV-2 infections Post -vaccination breakthrough COVID-19 cases The two ways to get new drugs Develop novel antiviral drugs for SARS-CoV-2 Repurpose existing FDA -approved drugs to treat COVID-19 Ivermectin is the most studied “repurposed” medication globally, in randomized clinical trials, retrospective studies and meta- analyses. Molnupiravir and Ivermectin Anti-SARS- CoV-2 Mechanisms, Pharmacokinetics and Pharmacodynamics Molnupiravir is a broad spectrum antiviral agent against SARS- CoV-2, SARS-CoV, seasonal or pandemic influenza and MERS corona virus Ivermectin is an FDA-approved, WHO essential drug used as broad spectrum antiparasitic, antibiotic and which has demonstrated broad spectrum antiviral activity against RNA viruses, including HIV, Zika, MERS corona virus The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro https://www.sciencedirect.com/science/article/pii/S0166354220302011 5000-fold inhibition of SARS-CoV-2, (99.98% at 48 hours The inhibitory concentration IC50 of Molnupiravir shows it to be a more potent anti-SARS-CoV-2 agent, compared to Ivermectin in vitro. Both molnupiravir and ivermectin are well absorbed after oral dosing Tmax of molnupiravir being 1-1.75 hours, With a half life of 7 hours Tmax of ivermectin is 4-6 hours Very long half life of 81-91 hours Ivermectin, being lipophilic has a large volume of distribution Ivermectin has the ability to accumulate in the lungs The anti-SARS-CoV-2 actions, both of molnupiravir and ivermectin, are dose and concentration dependent Molnupiravir active metabolite (NHC-5’ Triphosphate), acts as a competitive alternative substrate for viral RNA causing viral mutagenesis or mutations, which leads to viral error catastrophe and extinction of replication There is some concern about the safety of NHC -nucleoside triphosphate, which is also mutagenic to mammalian cells Ivermectin, multifarious actions, Binding to SARS-CoV-2 spike protein S Reducing cell entry via human ACE2 receptors Reducing viral transcription Inhibition of cytokine production and inflammation (not yet been shown for molnupiravir) Complimentary pharmacokinetics and pharmacodynamics of the drugs May be additive or synergistic This should be further investigated in anti-SARS- CoV-2 antiviral combination therapy. A combination of molnupiravir with Ivermectin putatively, in effects on RdRP or cytokine release. Cost https://www.who.int/selection_medicines/committees/expert/21/reviews/Ivermectin_Review1.pdf The cost for a package of 100 tablets of 3 mg ivermectin is $2.96. Say, 12mg per day for 5 days = $0.53 Safety http://www.vigiaccess.org https://www.who-umc.org/vigibase/vigibase/ Efficacy Ivermectin https://pubmed.ncbi.nlm.nih.gov/34145166/ For deaths, average risk ratio 0.38, (62% benefit) (moderate-certainty evidence https://ivmmeta.com Early treatment Late treatment Prophylaxis https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub2/epdf/full Main results, Treating people in hospital with COVID-19 We don't know whether ivermectin compared with placebo or usual care, 28 days after treatment:– leads to more or fewer deaths worsens or improves patients' condition assessed by need for ventilation or oxygen increases or reduces unwanted events Preventing COVID-19 We don't know whether ivermectin leads to more or fewer deaths compared with no drug
·youtube.com·
Ivermectin or Molnupiravir - YouTube
TFNT11 The FDA's BIG mistake
TFNT11 The FDA's BIG mistake
The FDA has been assuming that nearly all of the adverse events reported in VAERS have been due to "over-reporting" of "background events." In short, there is nothing to see here: it's all noise. This
·rumble.com·
TFNT11 The FDA's BIG mistake
Fully Vaccinated Are COVID 'Super-Spreaders,' Says Inventor of mRNA
Fully Vaccinated Are COVID 'Super-Spreaders,' Says Inventor of mRNA
On the latest episode of "The Hidden Gateway" podcast, Dr. Robert Malone, recognized for his role in inventing mRNA vaccine technology, said, "The idea that if you have a workplace where everybody's vaccinated, you're not going to have virus spread is totally false. A total lie."
·greenmedinfo.com·
Fully Vaccinated Are COVID 'Super-Spreaders,' Says Inventor of mRNA
Episode 237 THE TURNING POINT - The HighWire
Episode 237 THE TURNING POINT - The HighWire
It’s Mandate Mayhem! Southwest Airlines in Disarray; Is Biden’s Vaccine Order Legal?; The Pushback Against Tyranny Goes Viral!; Tech CEO’s New Mandate-Free Job Site Guests: Tammy Clark, Kristen Meghan, Andrew Crapuchettes
·thehighwire.com·
Episode 237 THE TURNING POINT - The HighWire
Episode 236 W.H.O. IS TO BLAME - The HighWire
Episode 236 W.H.O. IS TO BLAME - The HighWire
Fauci & Becerra Get Ripped A New One; Bombshell W.H.O. Exposé Through The Lens of A Pandemic; More U.S. Health Officials Jump Ship #WhoIsLyingToYou #HindSight2020 #Fauci #HughHewitt #RandPaul #XavierBecerra #NIH #DHHS #NIAID #NaturalImmunity #NaturallyAcquiredImmunity #WHO #Timewarp #SoumyaSwaminathan #GlobalVaccineSafetySummit #VaccineSafety #VaccineSideEffects #Proof #TheHighwire #DelBigtree #HW236
·thehighwire.com·
Episode 236 W.H.O. IS TO BLAME - The HighWire
Leaked Dept. of Defense Document Reveals Evidence of Widespread
Leaked Dept. of Defense Document Reveals Evidence of Widespread
A leaked Department of Defense document first reported on by attorney Tom Rentz reveals high rates of "breakthrough" infections (4% of which died) and hospitalizations within a cohort of 5.6 million Medicare beneficiaries all of whom were fully vaccinated.
·greenmedinfo.com·
Leaked Dept. of Defense Document Reveals Evidence of Widespread
TFNT9 CDC and FDA vaccine committees fail to spot any safety signals (15 minute version) Steve Kirsch
TFNT9 CDC and FDA vaccine committees fail to spot any safety signals (15 minute version) Steve Kirsch
I tried to tell them that there were huge safety signals being generated in VAERS and that the CDC detection algorithm was flawed. They ignored me. So now they get to star in their own video where I expose the total incompetence of all the committee members. Not only did they FAIL to spot over 1,000 safety signals on their own, but even after it was expressly pointed out to them, they couldn't recognize them either. This is unacceptable. They should all resign. America deserves better than this. Slides: https://www.skirsch.com/covid/TFNT9.pdf Full 60 minute video: https://rumble.com/vn3y22-tfnt9-cdc-and-fda-vaccine-committee-members-should-resign-for-failing-to-sp.html Follow me at gab.com/stkirsch
·tv.gab.com·
TFNT9 CDC and FDA vaccine committees fail to spot any safety signals (15 minute version) Steve Kirsch
TFNT10 Myocarditis deception
TFNT10 Myocarditis deception
This video explains what the real myocarditis rates are based on the VAERS data. The rates are as high as 1 in 318 for 16-year-old boys an elevation of over 1,000 times weekly baseline. Nobody is meas
·rumble.com·
TFNT10 Myocarditis deception
Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection - PubMed
Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection - PubMed
There is an emergency need for early ambulatory treatment of Coronavirus Disease 2019 (COVID-19) in acutely ill patients in an attempt to reduce disease progression and the risks of hospitalization and death. Such management should be applied in high-risk patients age > 50 years or with one or mo …
·pubmed.ncbi.nlm.nih.gov·
Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection - PubMed
Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatientambulatory) residents
Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatientambulatory) residents
The outbreak of COVID-19 from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread all over the world with tremendous morbidity and mortality in the elderly. In-hospital treatment addresses the multifaceted nature of the illness including ...
·ncbi.nlm.nih.gov·
Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatientambulatory) residents
! + Meeting of the COVID-19 Giants with Geert Vanden Bossche and Robert Malone MD - YouTube
! + Meeting of the COVID-19 Giants with Geert Vanden Bossche and Robert Malone MD - YouTube
Tremendous privilege for me to host the first live discussion between two stalwarts in the COVID-19 pandemic. Both men have taken an ethical stand to focus on science and not be afraid to share their expertise. The world now stands at a crossroads again. Where do we plant our next step? Geert Vanden Bossche - Expert vaccine developer (Belgium) Robert Malone MD - Inventor of mRNA vaccines (USA) Time to listen and be open to change. McMillan Research https://mcmillanresearch.com/
·youtu.be·
! + Meeting of the COVID-19 Giants with Geert Vanden Bossche and Robert Malone MD - YouTube